Effect of COVID-19 on Glycemic Control, Insulin Resistance, and pH in Elderly Patients With Type 2 Diabetes
Open Access
- 23 February 2023
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 15 (2) , e35390
Abstract
Background The coronavirus disease of 2019 (COVID-19) was spread all over the world, while diabetes mellitus (DM) remains the most prevalent chronic disease worldwide. Aims This study aims to investigate the effect of COVID-19 on glycemic control, insulin resistance (IR), and pH in elderly patients with type 2 diabetes. Methods A retrospective study was conducted on patients with type 2 DM who were diagnosed with COVID-19 infection in the central hospitals of the Tabuk region. Patient data were collected from September 2021 to August 2022. Four non-insulin-based insulin resistance indexes were calculated for patients: the triglyceride-glucose (TyG) index, the triglyceride glucose-body mass index (TyG-BMI) index, the triglyceride to high-density lipoprotein cholesterol (TG/HDL) ratio, and the metabolic score for insulin resistance (METS-IR). Results Patients showed increased serum fasting glucose and blood HbA1c associated with a high TyG index, TyG-BMI index, TG/HDL ratio, and METS-IR as compared with results before COVID-19. Moreover, during COVID-19, patients revealed a reduction in pH, associated with a reduction in cBase and bicarbonate, and an elevation in PaCO2 as compared with their results before COVID-19. After complete remission, all patients’ results turn back to their level before COVID-19. Conclusions Patients with type 2 DM who catch the COVID-19 infection suffer from dysregulation of glycemic control and elevated insulin resistance associated with a significant reduction in their pH.Keywords
This publication has 30 references indexed in Scilit:
- COVID-19, SARS and MERS: are they closely related?Clinical Microbiology and Infection, 2020
- Health Consequences of Sarcopenic Obesity: A Narrative ReviewFrontiers in Endocrinology, 2020
- Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future ManagementMetabolic Syndrome and Related Disorders, 2020
- Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in ChinaClinical Research in Cardiology, 2020
- Association between insulin resistance and the development of cardiovascular diseaseCardiovascular Diabetology, 2018
- Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategiesNature Reviews Endocrinology, 2018
- METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetesEuropean Journal of Endocrinology, 2018
- Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic IndividualsPLOS ONE, 2016
- Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterolMetabolism, 2011
- The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic ClampThe Journal of Clinical Endocrinology & Metabolism, 2010